...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith funding???

I think the question was raised, perhaps by tada, given that ZE appears to be running on financial fumes at best then perhaps something is in the works? I have not seen the details of the Pfizer TNBC trial but perhaps there is more to it than just providing their drug for the trial? Are they providing some funds as well? After the AGM Don was headed to China and I never heard the results from that. I'm just speculating that something may be in the works to explain how they keep operating. GLTA toinv

Share
New Message
Please login to post a reply